DUBLIN, Ohio--(BUSINESS WIRE)--Macrophage Therapeutics, Inc. a subsidiary of Navidea Biopharmaceuticals, Inc. (NYSE MKT:NAVB), announces that James Goldschmidt, Ph.D., Macrophage Therapeutics’ Chief Operating Officer, will present at the Biotechnology Industry Organization (BIO) 2015 International Convention on Tuesday, June 16, 2015, at 3:00 p.m. EDT in Theater 1. The conference will be held at The Pennsylvania Convention Center (June 15-18, 2015, Philadelphia, PA).
Help employers find you! Check out all the jobs and post your resume.
